CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 4 Option exercise EVP, International Markets acquired 20,598 shares (option exercise)
- 4 Option exercise EVP, Chief Financial Officer acquired 18,430 shares (option exercise)
- 4 Option exercise See "Remarks" acquired 4,828 shares (option exercise)
- 4 Open-market sale Executive VP, Global R&D sold 7,590 shares at $8.14 ($61,799)
- 4 Open-market sale Executive VP Global Operations sold 9,797 shares at $8.14 ($79,769)
- 4 Open-market sale EVP, North America Commercial sold 4,862 shares at $8.14 ($39,587)
- 4 Open-market sale Exec. VP, European Commercial sold 20,598 shares at $8.14 ($167,713)
- 8-K Event Executive or director change
- 4 Option exercise EVP, Chief Financial Officer acquired 6,629 shares (option exercise)
- SC 13G/A Stake Amended Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Exec. VP Chief Legal Officer sold 6,110 shares at $9.06 ($55,358)
- 4 Option exercise President and CEO acquired 26,867 shares (option exercise)
- 4 Option exercise EVP, International Markets acquired 15,523 shares (option exercise)
- 4 Open-market sale Executive VP, Global R&D sold 6,116 shares at $9.06 ($55,412)
- 4 Open-market sale Executive VP Global Operations sold 3,583 shares at $9.06 ($32,464)
- 4 Open-market sale EVP, North America Commercial sold 4,138 shares at $9.06 ($37,491)
- 4 Open-market sale Exec. VP, European Commercial sold 13,135 shares at $9.06 ($119,010)
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 27 of 128 · 2,555 filings